Alerts will be sent to your verified email
Verify Email
GUJINJEC
|
Guj. Inject (Kerala)
|
Kabra Drugs
|
Vineet Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.55 % | 65.41 % | 6.26 % |
|
5yr average Equity Multiplier
|
0.11 | -11.28 | 3.18 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.0 | 1.36 |
|
5yr Avg Net Profit Margin
|
-175.28 % | 0.0 | 1.11 % |
|
Price to Book
|
2.78 | 7.92 | 1.0 |
|
P/E
|
27.88 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-14.62 Days | 0.0 | 89.15 Days |
|
Inventory Days
|
38.61 Days | 0.0 | 66.38 Days |
|
Days Receivable
|
0.0 | 0.0 | 80.91 Days |
|
Days Payable
|
156.02 Days | 0.0 | 81.06 Days |
|
5yr Average Interest Coverage Ratio
|
298.1 | -836.53 | 2.14 |
|
5yr Avg ROCE
|
2.0 % | 64.57 % | 14.46 % |
|
5yr Avg Operating Profit Margin
|
-279.73 % | 0.0 | 3.72 % |
|
5 yr average Debt to Equity
|
-0.62 | -6.16 | 0.69 |
|
5yr CAGR Net Profit
|
n/a | 65.28 % | n/a |
|
5yr Average Return on Assets
|
-116.01 % | -21.32 % | 1.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.0 | 35.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Inject (Kerala)
|
Kabra Drugs
|
Vineet Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|